Pan-immune-inflammation value predicts survival in inflammatory breast cancer patients

Inflammatory breast cancer (IBC) is a rare and aggressive breast cancer subtype with poor survival. Identifying novel biomarkers is needed to predict survival for this highly progressive form of breast cancer. In this retrospective study, we investigated pan-immune-inflammation value (PIV), a novel...

Full description

Saved in:
Bibliographic Details
Main Authors: Yingjia Hu, Jian Li, Mingyu Wang, Xinyi Wang, Jiankang Li, Hongfei Ji, Xingjian Niu
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-05-01
Series:Experimental Biology and Medicine
Subjects:
Online Access:https://www.ebm-journal.org/articles/10.3389/ebm.2025.10493/full
Tags: Add Tag
No Tags, Be the first to tag this record!